Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

02 mai 2018 08h00 HE | Source: Atlantic Healthcare plc

Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis

Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical...
30 mai 2017 08h00 HE | Source: Atlantic Healthcare plc

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

CAMBRIDGE, U.K., May 30, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
22 mai 2017 08h00 HE | Source: Atlantic Healthcare plc

Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication

CAMBRIDGE, U.K., May 22, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...